[Clinical values of palliative gastrectomy for late-staged gastric cancer].
OBJECTIVE
To investigate the clinical importance of palliative gastrectomy for late-staged gastric cancer.


METHODS
From June 1994 to October 2001, 95 patients with late-staged gastric cancer underwent palliative operation. Clinicopathological and prognostic parameters between 64 patients with palliative gastrectomy (PG group) and 31 patients with unresectable operation (UO group) was compared retrospectively.


RESULTS
The age and gender ratios were not different between the two groups. The incidence of large volume (diameter > or = 8 cm), serosal invasion (T(4)) and late TNM stage (IV stage) were significantly higher in the UO group than that in the PG group. There was no difference in peritoneal dissemination, distant lymph node and hepatic metastasis, and tumor location between the two groups. The one- and two-year survival of the patients in the PG group was 48.1% and 23.1%, and significantly better than 13.5% and 0 in the UO group.


CONCLUSIONS
Palliative gastrectomy, compared with unresectable operation, can improve the prognosis of the patients with late-staged gastric cancer even with peritoneal dissemination, distant lymph node and hepatic metastasis, and surrounding organ invasion.
Cai
Shi-rong
SR
Department of Gastrointestinal and Pancreatic Surgery, First Affiliated Hospital, Zhongshan University, Guangzhou 510080, China.
He
Yu-long
YL
Huang
Mei-jin
MJ
Dong
Wen-guang
WG
Peng
Jun-sheng
JS
Zhan
Wen-hua
WH
Wang
Jian-ping
JP
D000328:Adult; D000368:Aged; D005260:Female; D005743:Gastrectomy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D010166:Palliative Care; D013274:Stomach Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D015996:Survival Rate